It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A tendon’s ordered extracellular matrix (ECM) is essential for transmitting force but is also highly prone to injury. How tendon cells embedded within and surrounding this dense ECM orchestrate healing is not well understood. Here, we identify a specialized quiescent Scx+/Axin2+ population in mouse and human tendons that initiates healing and is a major functional contributor to repair. Axin2+ cells express stem cell markers, expand in vitro, and have multilineage differentiation potential. Following tendon injury, Axin2+-descendants infiltrate the injury site, proliferate, and differentiate into tenocytes. Transplantation assays of Axin2-labeled cells into injured tendons reveal their dual capacity to significantly proliferate and differentiate yet retain their Axin2+ identity. Specific loss of Wnt secretion in Axin2+ or Scx+ cells disrupts their ability to respond to injury, severely compromising healing. Our work highlights an unusual paradigm, wherein specialized Axin2+/Scx+ cells rely on self-regulation to maintain their identity as key organizers of tissue healing.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Massachusetts General Hospital, Center for Regenerative Medicine, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard Medical School, Department of Orthopedic Surgery, Massachusetts General Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard Stem Cell Institute, Cambridge, USA (GRID:grid.511171.2)
2 Massachusetts General Hospital, Center for Regenerative Medicine, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard Medical School, Department of Medicine, Massachusetts General Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
3 Harvard University, John A. Paulson School of Engineering and Applied Sciences, Cambridge, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X); Harvard University, Wyss Institute for Biologically Inspired Engineering, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
4 Massachusetts General Hospital, Center for Regenerative Medicine, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard University, Department of Human Evolutionary Biology, Cambridge, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X)
5 Massachusetts General Hospital, Center for Regenerative Medicine, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
6 Harvard Medical School, The Center for Cancer Research, Massachusetts General Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
7 Harvard Medical School, Department of Orthopedic Surgery, Massachusetts General Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
8 Harvard University, Department of Human Evolutionary Biology, Cambridge, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X); Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623)
9 Massachusetts General Hospital, Center for Regenerative Medicine, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard Stem Cell Institute, Cambridge, USA (GRID:grid.511171.2); Harvard Medical School, Department of Medicine, Massachusetts General Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)